Page last updated: 2024-09-02

ecteinascidin 743 and Carcinoma, Lobular

ecteinascidin 743 has been researched along with Carcinoma, Lobular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bayever, E; Del Prete, SA; Goldstein, LJ; Gurtler, J; Michiels, B; Semiglazov, VF; Tjulandin, S	1

Trials

1 trial(s) available for ecteinascidin 743 and Carcinoma, Lobular

Article	Year
Trabectedin as a single-agent treatment of advanced breast cancer after anthracycline and taxane treatment: a multicenter, randomized, phase II study comparing 2 administration regimens. Clinical breast cancer, 2014, Volume: 14, Issue:6 Topics: Adolescent; Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Dioxoles; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Taxoids; Tetrahydroisoquinolines; Trabectedin; Young Adult	2014

Article

Year

Trabectedin as a single-agent treatment of advanced breast cancer after anthracycline and taxane treatment: a multicenter, randomized, phase II study comparing 2 administration regimens.

Clinical breast cancer, 2014, Volume: 14, Issue:6

Topics: Adolescent; Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Dioxoles; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Taxoids; Tetrahydroisoquinolines; Trabectedin; Young Adult

2014